|
David A. Scheinberg M.D. Ph.D. has been a member of our Cancer Scientific Advisory Board since 1994. Dr. Scheinberg has been associated with Sloan-Kettering since 1986 where he is the Vincent Astor Chair and Member Leukemia Service; Chairman Molecular Pharmacology and Chemistry Program; Chairman Experimental Therapeutics Center; Member Clinical Immunology Service; and Head Laboratory of Hematopoietic Cancer Immunochemistry. He also holds the position of Professor of Medicine and Pharmacology Weill-Cornell Medical College. He received a B.A. from Cornell University and an M.D. and a Ph.D. in pharmacology and experimental therapeutics from The Johns Hopkins University School of Medicine. | 